期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | WIENER KLINISCHE WOCHENSCHRIFT LetPub Score 5.1
50 ratings
Rate
Reputation 6.3 Influence 3.7 Speed 7.0 | ||||||||||||||||
期刊簡稱 | WIEN KLIN WOCHENSCHR | ||||||||||||||||
ISSN | 0043-5325 | ||||||||||||||||
E-ISSN | 1613-7671 | ||||||||||||||||
h-index | 47 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 5.30%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/508 | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/wkwo | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Springer Vienna | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | AUSTRIA | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 2003 | ||||||||||||||||
每年文章數 | 126每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 60.22% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0043-5325%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[WIENER KLINISCHE WOCHENSCHRIFT] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:49:55 評論於 For example, experimental techniques such as PCR, western blot, and the usage methods of certain instruments(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:33:17 評論於 If the method is described for the first time, a detailed explanation is required, as a detailed description also reflects the rigor and thorough consideration of the research work; however, if the method has already been described in one's own published papers, a brief description of the method is sufficient, with references attached(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 09:54:15 評論於 When should the methods section be described in detail, and when can it be abbreviated?(0) 讚! | 八坂篷蔚 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 19:47:51 評論於 What is the standard procedure for using the laboratory?(0) 讚! | 深渊兴业 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 11:35:45 評論於 Anyway, this bear will not change its appearance, so as long as it doesn't fall, it's already lucky(0) 讚! | 凌霄高洁 |
作者: 筑阳慧秀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-02-17 22:52:30 評論於 Review speed: 3.0 | Submission acceptance rate: 5.0 Experience sharing: The review process is very slow, and meta rejections do not provide reasons(0) 讚! | 筑阳慧秀 |
作者: 铁头诗筠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-06-07 20:22:22 評論於 Review Speed: 6.0 Experience Sharing: Submitted for 3 months, status was always "with editor", and was eventually rejected without any explanation. If you're in a hurry, then don't submit(0) 讚! | 铁头诗筠 |
作者: 铁头诗筠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-06-07 10:03:42 評論於 Review Speed: 6.0 Experience Sharing: Submitted for 3 months and always in the status of "with editor", finally rejected completely without any explanation. If you are in a hurry, then don't submit(0) 讚! | 铁头诗筠 |
作者: 奕剑鹏天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-02-19 15:09:52 評論於 Review speed: 2.0 | Submission acceptance rate: 75.0 Experience sharing: I submitted a meta paper in early November 2016, and received revision comments by the end of December. After making some minor revisions based on the comments, the article was accepted for publication in January, which made the submission process relatively easy(0) 讚! | 奕剑鹏天 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us